Shares of TriSalus Life Sciences Inc. (trading on the Nasdaq Capital Market under the ticker symbol TLSI) fluctuate dynamically throughout active trading hours on public exchanges. Equity valuations respond directly to quarterly financial disclosures, commercial adoption rates of its proprietary Pressure-Enabled Drug Delivery devices, and broader market sentiment across the medical technology sector.